|
Nyxoah S.A. (NYXH) DCF Valuation
BE | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Nyxoah S.A. (NYXH) Bundle
Gain insight into your Nyxoah S.A. (NYXH) valuation analysis using our sophisticated DCF Calculator! Preloaded with real NYXH data, this Excel template enables you to adjust forecasts and assumptions to accurately determine Nyxoah S.A.'s intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .1 | .9 | 3.2 | 4.5 | 7.3 | 11.6 | 18.6 | 29.9 | 47.9 |
| Revenue Growth, % | 0 | 0 | 1134.78 | 261.97 | 40.99 | 60.25 | 60.25 | 60.25 | 60.25 | 60.25 |
| EBITDA | -6.9 | -11.0 | -25.6 | -29.1 | -43.8 | -4.4 | -7.0 | -11.2 | -17.9 | -28.7 |
| EBITDA, % | 100 | -15368.12 | -2884.98 | -904.25 | -967.8 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .5 | .6 | 1.7 | 2.0 | 2.5 | 6.1 | 9.7 | 15.5 | 24.9 | 39.9 |
| Depreciation, % | 100 | 898.55 | 195.07 | 62.65 | 54.28 | 83.38 | 83.38 | 83.38 | 83.38 | 83.38 |
| EBIT | -7.4 | -11.7 | -27.3 | -31.1 | -46.3 | -4.4 | -7.0 | -11.2 | -17.9 | -28.7 |
| EBIT, % | 100 | -16266.67 | -3080.05 | -966.89 | -1022.08 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 6.1 | 96.2 | 141.2 | 98.8 | 60.2 | 7.3 | 11.6 | 18.6 | 29.9 | 47.9 |
| Total Cash, percent | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.2 | 1.7 | 2.6 | 1.8 | 2.9 | 6.1 | 9.8 | 15.7 | 25.2 | 40.3 |
| Account Receivables, % | 100 | 2382.61 | 294.84 | 57.56 | 63.43 | 84.2 | 84.2 | 84.2 | 84.2 | 84.2 |
| Inventories | .0 | .1 | .4 | .9 | 3.5 | 4.7 | 7.6 | 12.1 | 19.4 | 31.1 |
| Inventories, % | 100 | 79.71 | 40.61 | 28.6 | 76.24 | 65.03 | 65.03 | 65.03 | 65.03 | 65.03 |
| Accounts Payable | 1.2 | .8 | 2.5 | 2.0 | 4.3 | 6.6 | 10.6 | 17.0 | 27.2 | 43.6 |
| Accounts Payable, % | 100 | 1181.16 | 280.99 | 60.73 | 94.34 | 91.02 | 91.02 | 91.02 | 91.02 | 91.02 |
| Capital Expenditure | -6.0 | -11.1 | -12.3 | -17.0 | -11.4 | -5.8 | -9.3 | -14.9 | -23.9 | -38.3 |
| Capital Expenditure, % | 100 | -15478.26 | -1386.97 | -530.12 | -252.12 | -80 | -80 | -80 | -80 | -80 |
| Tax Rate, % | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 |
| EBITAT | -7.5 | -11.8 | -30.7 | -32.3 | -44.8 | -4.3 | -6.9 | -11.1 | -17.8 | -28.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -14.0 | -22.2 | -40.8 | -47.6 | -55.0 | -6.3 | -9.1 | -14.6 | -23.3 | -37.4 |
| WACC, % | 7.17 | 7.17 | 7.17 | 7.17 | 7.16 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -69.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -38 | |||||||||
| Terminal Value | -738 | |||||||||
| Present Terminal Value | -522 | |||||||||
| Enterprise Value | -592 | |||||||||
| Net Debt | -9 | |||||||||
| Equity Value | -582 | |||||||||
| Diluted Shares Outstanding, MM | 28 | |||||||||
| Equity Value Per Share | -20.82 |
What You Will Get
- Authentic Nyxoah Data: Comprehensive financials – from revenue to EBIT – derived from actual and projected figures.
- Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Updates: Automatic recalculations to assess the effects of changes on Nyxoah’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
- Efficient and Precise: Avoid constructing models from the ground up while ensuring accuracy and adaptability.
Key Features
- Real-Life NYXH Data: Pre-filled with Nyxoah S.A.'s historical financials and future projections.
- Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures as needed.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
- User-Friendly Design: Intuitive, organized, and crafted for both professionals and novices.
How It Works
- 1. Access the Template: Download and open the Excel file containing Nyxoah S.A.'s (NYXH) data.
- 2. Modify Assumptions: Adjust key inputs such as growth projections, WACC, and capital expenditures.
- 3. View Immediate Results: The DCF model automatically calculates intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Nyxoah S.A. (NYXH)?
- Designed for Experts: A specialized tool tailored for analysts, CFOs, and consultants in the healthcare sector.
- Accurate Financials: Nyxoah's historical and projected financial data preloaded for precision.
- Forecast Simulation: Effortlessly test various scenarios and assumptions related to Nyxoah's performance.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Detailed step-by-step guidance ensures a smooth experience.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Nyxoah S.A. (NYXH) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Nyxoah S.A. (NYXH).
- Consultants: Deliver professional valuation insights on Nyxoah S.A. (NYXH) to clients quickly and accurately.
- Business Owners: Understand how innovative companies like Nyxoah S.A. (NYXH) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Nyxoah S.A. (NYXH).
What the Template Contains
- Pre-Filled DCF Model: Nyxoah S.A.’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Nyxoah S.A.’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.